References
- Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020 Jul 09;383(2):120–128. https://doi.org/10.1056/NEJMoa2015432
- Aguilar-Shea AL, Vera-García M, Güerri-Fernández R. Rapid antigen tests for the detection of SARS-CoV-2: A narrative review. Aten Primaria. 2021 Nov;53(9):102127. https://doi.org/10.1016/j.aprim.2021.102127
- Alsharif W, Qurashi A. Effectiveness of COVID- 19 diagnosis and management tools: A review. Radiography. 2021 May;27(2):682–687. https://doi.org/10.1016/j.radi.2020.09.010
- Araf Y, Akter F, Tang Y, Fatemi R, Parvez MSA, Zheng C, Hos‑ sain MG. Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines. J Med Virol. 2022 May;94(5):1825–1832. https://doi.org/10.1002/jmv.27588
- Asghari A, Naseri M, Safari H, Saboory E, Parsamanesh N. The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options. DNA Cell Biol. 2020 Oct 01;39(10):1741–1753. https://doi.org/10.1089/dna.2020.5703
- Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY). 2020 Jun 05;12(11):10087–10098. https://doi.org/10.18632/aging.103415
- Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, Bartlett RH, Tonna JE, Hyslop R, Fanning JJ, et al.; Extra‑ corporeal Life Support Organization. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020 Oct;396(10257):1071–1078. https://doi.org/10.1016/S0140-6736(20)32008-0
- Belouzard S, Millet JK, Licitra BN, Whittaker GR. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012 Jun 20;4(6):1011–1033. https://doi.org/10.3390/v4061011
- Blain H, Rolland Y, Benetos A, Giacosa N, Albrand M, Miot S, Bousquet J. Atypical clinical presentation of COVID- 19 infection in residents of a long-term care facility. Eur Geriatr Med. 2020 Dec;11(6):1085–1088. https://doi.org/10.1007/s41999-020-00352-9
- Böger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID- 19. Am J Infect Control. 2021 Jan;49(1):21–29. https://doi.org/10.1016/j.ajic.2020.07.011
- Brümmer LE, Katzenschlager S, Gaeddert M, Erdmann C, Schmitz S, Bota M, Grilli M, Larmann J, Weigand MA, Pollock NR, et al. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis. PLoS Med. 2021 Aug 12;18(8):e1003735. https://doi.org/10.1371/journal.pmed.1003735
- Bwire GM, Majigo MV, Njiro BJ, Mawazo A. Detection profile of SARS‐CoV‐2 using RT‐PCR in different types of clinical specimens: A systematic review and meta‐analysis. J Med Virol. 2021 Feb; 93(2):719–725. https://doi.org/10.1002/jmv.26349
- Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv. 2020;2020.02.05.20020107. https://doi.org/10.1101/2020.02.05.20020107
- Callaway E. Heavily mutated Omicron variant puts scientists on alert. Nature. 2021 Dec 02;600(7887):21. https://doi.org/10.1038/d41586-021-03552-w
- Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, Wen F, Huang X, Ning G, Wang W. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020 Dec;6(1):11. https://doi.org/10.1038/s41421-020-0147-1
- CDC. How to Protect Yourself & Others [Internet]. Atlanta (USA): Centers for Disease Control and Prevention; 2021 [cited 2022 Feb 20]. Available from https://www.cdc.gov/coronavirus/2019-ncov/prevent- getting-sick/ prevention.html
- Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, Yang Y, Liu B, Wang W, Wei C, et al. The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients. J Med Virol. 2020 Jul;92(7):833–840. https://doi.org/10.1002/jmv.25825
- Cheng Z, Zhou J, To KKW, Chu H, Li C, Wang D, Yang D, Zheng S, Hao K, Bossé Y, et al. Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A(H1N1) influenza and A(H7N9) influenza. J Infect Dis. 2015 Oct 15;212(8):1214–1221. https://doi.org/10.1093/infdis/jiv246
- Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, Ng YY, Chu MY, Chung TWH, Tam AR, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020 Jul;159(1):81–95. https://doi.org/10.1053/j.gastro.2020.03.065
- Choi GJ, Baek SH, Kim J, Kim JH, Kwon GY, Kim DK, Jung YH, Kim S. Fatal systemic capillary leak syndrome after SARS-CoV-2 vaccination in patient with multiple myeloma. Emerg Infect Dis. 2021 Nov;27(11):2973–2975. https://doi.org/10.3201/eid2711.211723
- Chua GT, Kwan MYW, Chui CSL, Smith RD, Cheung EC, Tian T, Leung MTY, Tsao SSL, Kan E, Ng WKC, et al. Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents following Comirnaty vaccination. Clin Infect Dis. 2021 Nov 28:ciab989. https://doi.org/10.1093/cid/ciab989
- Comirnaty, Summary of product characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 9]. Available from https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdf
- Cornillez-Ty CT, Liao L, Yates JR 3rd, Kuhn P, Buchmeier MJ. Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling. J Virol. 2009 Oct; 83(19):10314–10318. https://doi.org/10.1128/JVI.00842-09
- Correale P, Mutti L, Pentimalli F, Baglio G, Saladino RE, Sileri P, Giordano A. HLA-B*44 and C*01 prevalence correlates with covid19 spreading across Italy. Int J Mol Sci. 2020 Jul 23;21(15):5205. https://doi.org/10.3390/ijms21155205
- COVID- 19 Vaccine AstraZeneca, Summary of product characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 20]. Available from https://www.ema.europa.eu/en/documents/product-information/covid-19-vaccine-astrazeneca-product-information-approved-chmp-29-january-2021-pending-endorsement_en.pdf
- COVID-19 Vaccine AstraZeneca, Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/ vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-product-information_en.pdf
- COVID-19 Vaccine Janssen, Summary of product characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 20]. Available from https://www.ema.europa.eu/en/documents/product-information/jcovden-previously-covid-19-vaccine-janssen-epar-product-information_en.pdf
- Davies JP, Almasy KM, McDonald EF, Plate L. Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus nonstructural proteins identifies unique and shared host-cell dependencies. ACS Infect Dis. 2020 Dec 11;6(12):3174–3189. https://doi.org/10.1021/acsinfecdis.0c00500
- de Haan CAM, Vennema H, Rottier PJM. Assembly of the coronavirus envelope: homotypic interactions between the M proteins. J Virol. 2000 Jun;74(11):4967–4978. https://doi.org/10.1128/jvi.74.11.4967-4978.2000
- Du L, Zhao G, Lin Y, Chan C, He Y, Jiang S, Wu C, Jin DY, Yuen KY, Zhou Y, et al. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine. 2008 Mar;26(13):1644–1651. https://doi.org/10.1016/j.vaccine.2008.01.025
- Duchene S, Featherstone L, Haritopoulou-Sinanidou M, Ram‑ baut A, Lemey P, Baele G. Temporal signal and the phylodynamic threshold of SARS-CoV-2. Virus Evol. 2020 Aug 19;6(2):veaa061. https://doi.org/10.1093/ve/veaa061
- ECDC. Options for the use of rapid antigen tests for COVID- 19 in the EU/EEA and the UK [Internet]. Stockholm (Sweden): European Centre for Disease Prevention and Control; 2020 [cited 2021 Apr 02]. Available from https://www.ecdc.europa.eu/sites/default/files/documents/Options-use-of-rapid-antigen-tests-for-COVID-19_0.pdf
- Englisch CN, Tschernig T, Flockerzi F, Meier C, Bohle RM. Lesions in the lungs of fatal corona virus disease Covid- 19. Ann Anat. 2021 Mar;234:151657. https://doi.org/10.1016/j.aanat.2020.151657
- Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DS, Mishra S, Crispim MAE, Sales FCS, Hawryluk I, McCrone JT, et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021 May 21;372(6544):815–821. https://doi.org/10.1126/science.abh2644
- Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1–23. https://doi.org/10.1007/978-1-4939-2438-7_1
- Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C. Omicron SARS-CoV-2 variant: what we know and what we don’t. Anaesth Crit Care Pain Med. 2022 Feb;41(1):100998. https://doi.org/10.1016/j.accpm.2021.100998
- Flisiak R, Horban A, Jaroszewicz J, Kozielewicz D, Pawłowska M, Parczewski M, Piekarska A, Simon K, Tomasiewicz K, Zarębska-Michaluk D. [Zalecenia postępowania w zakażeniach SARS-CoV-2 Polskiego Towarzystwa Epidemiologów i Lekarzy Chorób Zakaźnych, na dzień 26 kwietnia 2021] (in Polish) [Internet]. PTEiLChZ 30.04.2021 [cited 2022 Feb 04]. Available from https://www.mp.pl/covid19/zalecenia/265853,zalecenia-postepowania-w-zakazeniach-sars-cov-2-polskiego-towarzystwa-epidemiologow-i-lekarzy-chorob-zakaznych-26042021
- Franchini M, Liumbruno GM, Pezzo M. COVID‐19 vaccine‐ associated immune thrombosis and thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol. 2021 Aug;107(2):173–180. https://doi.org/10.1111/ejh.13665
- Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, Panebianco V, Andreoli C, Colaiacomo MC, Zingaropoli MA, et al. Chest CT score in COVID- 19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020 Dec;30(12): 6808–6817. https://doi.org/10.1007/s00330-020-07033-y
- Gao G, Guo X, Goff SP. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science. 2002 Sep 06; 297(5587):1703–1706. https://doi.org/10.1126/science.1074276
- Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, Broder KR, Gee J, Weintraub E, Shimabukuro T, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices – United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 09;70(27):977–982. https://doi.org/10.15585/mmwr.mm7027e2
- Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Monte‑ jano R, Spinner CD, Galli M, Ahn MY, Nahass RG, et al.; GS-US-540-5773 Investigators. Remdesivir for 5 or 10 days in patients with severe Covid- 19. N Engl J Med. 2020 Nov 05;383(19):1827–1837. https://doi.org/10.1056/nejmoa2015301
- Grams SE, Moonsamy PV, Mano C, Oksenberg JR, Begovich AB. Two new HLA-B alleles, B*4422 and B*4704, identified in a study of families with autoimmunity. Tissue Antigens. 2002 Apr;59(4):338–340. https://doi.org/10.1034/j.1399-0039.2002.590417.x
- Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020 Jul 28;71(15):778–785. https://doi.org/10.1093/cid/ciaa310
- Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, et al.; STOP-COVID Investigators. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020 Nov 01;180(11):1436–1447. https://doi.org/10.1001/jamainternmed.2020.3596
- Hachim MY, Al Heialy S, Hachim IY, Halwani R, Senok AC, Maghazachi AA, Hamid Q. Interferon-induced transmembrane protein (IFITM3) is upregulated explicitly in SARS-CoV-2 infected lung epithelial cells. Front Immunol. 2020 Jun 10;11:1372. https://doi.org/10.3389/fimmu.2020.01372
- Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Peacock SJ, et al.; COVID-19 Genomics UK (COG-UK) Consortium. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021 Jul; 19(7):409–424. https://doi.org/10.1038/s41579-021-00573-0
- Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pöhlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014 Jan 15;88(2):1293–1307. https://doi.org/10.1128/JVI.02202-13
- Hirotsu Y, Maejima M, Shibusawa M, Nagakubo Y, Hosaka K, Amemiya K, Sueki H, Hayakawa M, Mochizuki H, Tsutsui T, et al. Comparison of automated SARS-CoV-2 antigen test for COVID- 19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients. Int J Infect Dis. 2020 Oct;99:397–402. https://doi.org/10.1016/j.ijid.2020.08.029
- Hoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020 May21;78(4):779–784.e5. https://doi.org/10.1016/j.molcel.2020.04.022
- Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, et al.; RECOV‑ ERY Collaborative Group. Effect of Hydroxychloroquine in Hospitalized Patients with Covid- 19. N Engl J Med. 2020 Nov 19; 383(21): 2030–2040. https://doi.org/10.1056/NEJMoa2022926
- Hu B, Zeng LP, Yang XL, Ge XY, Zhang W, Li B, Xie JZ, Shen XR, Zhang YZ, Wang N, et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog. 2017 Nov 30;13(11):e1006698. https://doi.org/10.1371/journal.ppat.1006698
- Huang Y, Yang C, Xu Xf, Xu W, Liu Sw. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID- 19. Acta Pharmacol Sin. 2020 Sep; 41(9): 1141–1149. https://doi.org/10.1038/s41401-020-0485-4
- Hussain M, Jabeen N, Raza F, Shabbir S, Baig AA, Amanullah A, Aziz B. Structural variations in human ACE2 may influence its binding with SARS‐CoV‐2 spike protein. J Med Virol. 2020 Sep; 92(9):1580–1586. https://doi.org/10.1002/jmv.25832
- Jung ES, Cheon JH, Lee JH, Park SJ, Jang HW, Chung SH, Park MH, Kim TG, Oh HB, Yang SK, et al. HLA-C*01 is a risk factor for Crohn’s disease. Inflamm Bowel Dis. 2016 Apr;22(4):796–806. https://doi.org/10.1097/MIB.0000000000000693
- Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID- 19 pandemic. Lancet. 2021 Dec 11;398(10317): 2126–2128. https://doi.org/10.1016/S0140-6736(21)02758-6
- Kashour Z, Riaz M, Garbati MA, AlDosary O, Tlayjeh H, Ger‑ beri D, Murad MH, Sohail MR, Kashour T, Tleyjeh IM. Efficacy of chloroquine or hydroxychloroquine in COVID- 19 patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2021 Jan 01;76(1):30–42. https://doi.org/10.1093/jac/dkaa403
- Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The architecture of SARS-CoV-2 transcriptome. Cell. 2020 May; 181(4):914–921.e10. https://doi.org/10.1016/j.cell.2020.04.011
- Koçak Tufan Z, Kayaaslan B, Mer M. COVID- 19 and sepsis. Turk J Med Sci. 2021 Dec 17;51 SI-1:3301–3311. https://doi.org/10.3906/sag-2108-239
- Kumar S, Thambiraja TS, Karuppanan K, Subramaniam G. Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein. J Med Virol. 2022 Apr;94(4):1641–1649. https://doi.org/10.1002/jmv.27526
- Lagevrio, Summary of Product Characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 15]. Available from https://www.ema.europa.eu/en/documents/referral/lagevrio-also-known-molnupiravir-mk-4482-covid-19-article-53-procedure-conditions-use-conditions_en.pdf
- Lan SH, Lai CC, Huang HT, Chang SP, Lu LC, Hsueh PR. Tocilizumab for severe COVID- 19: a systematic review and meta-analysis. Int J Antimicrob Agents. 2020 Sep;56(3):106103. https://doi.org/10.1016/j.ijantimicag.2020.106103
- Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The incubation period of corona-virus disease 2019 (CoVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020 May 05; 172(9):577–582. https://doi.org/10.7326/M20-0504
- Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251–2261. https://doi.org/10.1007/s00405-020-05965-1
- Lei J, Kusov Y, Hilgenfeld R. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antiviral Res. 2018 Jan; 149:58–74. https://doi.org/10.1016/j.antiviral.2017.11.001
- Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, et al. Clinical and virological data of the first cases of COVID- 19 in Europe: a case series. Lancet Infect Dis. 2020 Jun; 20(6):697–706. https://doi.org/10.1016/S1473-3099(20)30200-0
- Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016 Sep 29;3(1):237–261. https://doi.org/10.1146/annurev-virology-110615-042301
- Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, Ding S, He Y, Liang C, Lee JC, et al. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog. 2013 Jan;9(1):e1003124. https://doi.org/10.1371/journal.ppat.1003124
- Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020a Dec;9(1):45. https://doi.org/10.1186/s40249-020-00662-x
- Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020b Apr;10(2): 102–108. https://doi.org/10.1016/j.jpha.2020.03.001
- Lim Y, Ng Y, Tam J, Liu D. Human Coronaviruses: A Review of Virus-Host Interactions. Diseases. 2016 Jul 25;4(4):26. https://doi.org/10.3390/diseases4030026
- Lin L, Liu Y, Tang X, He D. The disease severity and clinical outcomes of the SARS-CoV-2 variants of concern. Front Public Health. 2021 Nov 30;9:775224. https://doi.org/10.3389/fpubh.2021.775224
- Lisboa Bastos M, Tavaziva G, Abidi SK, Campbell JR, Haraoui LP, Johnston JC, Lan Z, Law S, MacLean E, Trajman A, et al. Diagnostic accuracy of serological tests for covid- 19: systematic review and meta-analysis. BMJ. 2020 Jul 01;370:m2516. https://doi.org/10.1136/bmj.m2516
- Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, et al.; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb; 397(10275):671–681. https://doi.org/10.1016/S0140-6736(21)00234-8
- Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 Feb;395(10224):565–574. https://doi.org/10.1016/S0140-6736(20)30251-8
- Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochem Biophys Res Commun. 2020 May; 526(1):165–169. https://doi.org/10.1016/j.bbrc.2020.03.047
- Makoah NA, Tipih T, Litabe MM, Brink M, Sempa JB, Goedhals D, Burt FJ. A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19. Future Virol. 2021 Nov:10.2217/fvl-2021-0211. https://doi.org/10.2217/fvl-2021-0211
- Malik JA, Ahmed S, Mir A, Shinde M, Bender O, Alshammari F, Ansari M, Anwar S. The SARS-CoV-2 mutations versus vaccine effectiveness: new opportunities to new challenges. J Infect Public Health. 2022 Feb;15(2):228–240. https://doi.org/10.1016/j.jiph.2021.12.014
- Mao R, Nie H, Cai D, Zhang J, Liu H, Yan R, Cuconati A, Block TM, Guo JT, Guo H. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog. 2013 Jul 11;9(7):e1003494. https://doi.org/10.1371/journal.ppat.1003494
- McBride R, van Zyl M, Fielding B. The coronavirus nucleocapsid is a multifunctional protein. Viruses. 2014 Aug 07;6(8):2991–3018. https://doi.org/10.3390/v6082991
- McDonald I, Murray SM, Reynolds CJ, Altmann DM, Boyton RJ. Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2. npj Vaccines. 2021 Dec;6(1):74. https://doi.org/10.1038/s41541-021-00336-1
- McFadyen JD, Stevens H, Peter K. The emerging threat of (micro) thrombosis in COVID- 19 and its therapeutic implications. Circ Res. 2020 Jul 31;127(4):571–587. https://doi.org/10.1161/CIRCRESAHA.120.317447
- Meagher JL, Takata M, Gonçalves-Carneiro D, Keane SC, Rebendenne A, Ong H, Orr VK, MacDonald MR, Stuckey JA, Bieniasz PD, et al. Structure of the zinc-finger antiviral protein in complex with RNA reveals a mechanism for selective targeting of CG-rich viral sequences. Proc Natl Acad Sci USA. 2019 Nov 26; 116(48):24303–24309. https://doi.org/10.1073/pnas.1913232116
- Mustafa Hellou M, Górska A, Mazzaferri F, Cremonini E, Gentilotti E, De Nardo P, Poran I, Leeflang MM, Tacconelli E, Paul M. Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis. Clin Microbiol Infect. 2021 Mar;27(3):341–351. https://doi.org/10.1016/j.cmi.2020.11.002
- Nasreen S, Chung H, He S, Brown KA, Gubbay JB, Buchan SA, Fell DB, Austin PC, Schwartz KL, Sundaram ME, et al.; Canadian Immunization Research Network (CIRN) Provincial Collabora‑ tive Network (PCN) Investigators. Effectiveness of COVID- 19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nat Microbiol. 2022 Mar;7(3):379–385. https://doi.org/10.1038/s41564-021-01053-0
- Nguyen A, David JK, Maden SK, Wood MA, Weeder BR, Nel‑ lore A, Thompson RF. Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. J Virol. 2020 Jun 16;94(13):e00510-20. https://doi.org/10.1128/JVI.00510-20
- Nieto-Torres JL, DeDiego ML, Verdiá-Báguena C, Jimenez-Guardeño JM, Regla-Nava JA, Fernandez-Delgado R, Castaño-Rodriguez C, Alcaraz A, Torres J, Aguilella VM, et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014 May 1;10(5):e1004077. https://doi.org/10.1371/journal.ppat.1004077
- O’Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, et al; Covid-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV antibody combination to prevent COVID-19. N Engl J Med. 2021 Sep 23;385(13):1184–1195. https://doi.org10.1056/NEJMoa2109682
- Ong DSY, Fragkou PC, Schweitzer VA, Chemaly RF, Moschopoulos CD, Skevaki C; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). How to interpret and use COVID- 19 serology and immunology tests. Clin Microbiol Infect. 2021 Jul;27(7):981–986. https://doi.org/10.1016/j.cmi.2021.05.001
- Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020 Mar 27;11(1):1620. https://doi.org/10.1038/s41467-020-15562-9
- Padoan A, Sciacovelli L, Basso D, Negrini D, Zuin S, Cosma C, Faggian D, Matricardi P, Plebani M. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study. Clin Chim Acta. 2020 Aug;507:164–166. https://doi.org/10.1016/j.cca.2020.04.026
- Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B, et al. SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J Med Virol. 2020 Sep; 92(9):1676–1680. https://doi.org/10.1002/jmv.25936
- Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009 Jun;7(6):439–450. https://doi.org/10.1038/nrmicro2147
- Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M. Venous thromboembolism in patients with COVID- 19: systematic review and meta-analysis. Thromb Res. 2020 Dec; 196:67–74. https://doi.org/10.1016/j.thromres.2020.08.020
- Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, Dushoff J, Mlisana K, Moultrie H. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. medRxiv. 2021; 2021.11.11.21266068. https://doi.org/10.1101/2021.11.11.21266068
- Pyrc K, Dijkman R, Deng L, Jebbink MF, Ross HA, Berkhout B, van der Hoek L. Mosaic structure of human coronavirus NL63, one thousand years of evolution. J Mol Biol. 2006 Dec;364(5):964–973. https://doi.org/10.1016/j.jmb.2006.09.074
- Ramanathan K, Shekar K, Ling RR, Barbaro RP, Wong SN, Tan CS, Rochwerg B, Fernando SM, Takeda S, MacLaren G, et al. Extracorporeal membrane oxygenation for COVID- 19: a systematic review and meta-analysis. Crit Care. 2021 Dec;25(1):211. https://doi.org/10.1186/s13054-021-03634-1
- Rambaut A, Loman N, Pybus O, Barclay W, Barrett J, Carabelli A, Connor T, Peacock T, Robertson D, Volz E. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations [Internet]. 2020 [cited 2022 Feb 04]. Available from https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563
- Ravi N, Cortade DL, Ng E, Wang SX. Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID- 19 testing landscape. Biosens Bioelectron. 2020 Oct;165:112454. https://doi.org/10.1016/j.bios.2020.112454
- Ravindra K, Malik VS, Padhi BK, Goel S, Gupta M. Asymptomatic infection and transmission of COVID-19 among clusters: systematic review and meta-analysis. Public Health. 2022 Feb;203:100–109. https://doi.org/10.1016/j.puhe.2021.12.003
- RoActemra, Summary of product characteristics[Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 15]. Available from https://www.ema.europa.eu/en/documents/product-information/roactemra-epar-product-information_en.pdf
- Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, et al.; ENSEMBLE Study Group. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021 Jun 10;384(23):2187–2201. https://doi.org/10.1056/NEJMoa2101544
- Sakai Y, Kawachi K, Terada Y, Omori H, Matsuura Y, Kamitani W. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication. Virology. 2017 Oct;510:165–174. https://doi.org/10.1016/j.virol.2017.07.019
- Santos JC, Passos GA. The high infectivity of SARS-CoV-2 B. 1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation. bioRxiv. 2020; 2020.12.29. 424708. https://doi.org/10.1101/2020.12.29.424708
- Schubert K, Karousis ED, Jomaa A, Scaiola A, Echeverria B, Gurzeler LA, Leibundgut M, Thiel V, Mühlemann O, Ban N. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat Struct Mol Biol. 2020 Oct;27(10):959–966. https://doi.org/10.1038/s41594-020-0511-8
- Severe Covid- 19 GWAS Group; Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernández J, Prati D, Baselli G, Asselta R, et al. Genomewide association study of severe COVID- 19 with respiratory failure. N Engl J Med. 2020 Oct 15; 383(16):1522–1534. https://doi.org/10.1056/NEJMoa2020283
- Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA. 2020 May 26;117(21):11727–11734. https://doi.org/10.1073/pnas.2003138117
- Sharma S, Patnaik SK, Thomas Taggart R, Kannisto ED, Enriquez SM, Gollnick P, Baysal BE. APOBEC3A cytidine deam-inase induces RNA editing in monocytes and macrophages. Nat Commun. 2015 Nov;6(1):6881. https://doi.org/10.1038/ncomms7881
- Singh AK, Singh A, Singh R, Misra A. Molnupiravir in COVID- 19: A systematic review of literature. Diabetes Metab Syndr. 2021 Nov; 15(6):102329. https://doi.org/10.1016/j.dsx.2021.102329
- Singh Tomar PP, Arkin IT. SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine. Biochem Biophys Res Commun. 2020 Sep;530(1):10–14. https://doi.org/10.1016/j.bbrc.2020.05.206
- Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019 Jan 14;11(1):59. https://doi.org/10.3390/v11010059
- Spikevax, Summary of product characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 20]. Available from https://www.ema.europa.eu/en/documents/product-information/spikevax-previously-covid-19-vaccine-moderna-epar-product-information_en.pdf
- Srinivasan S, Cui H, Gao Z, Liu M, Lu S, Mkandawire W, Narykov O, Sun M, Korkin D. Structural genomics of SARS-COV-2 indicates evolutionary conserved functional regions of viral proteins. Viruses. 2020 Mar 25;12(4):360. https://doi.org/10.3390/v12040360
- Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KHD, Dingens AS, Navarro MJ, Bowen JE, Tortorici MA, Walls AC, et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. 2020 Sep;182(5):1295–1310.e20. https://doi.org/10.1016/j.cell.2020.08.012
- Suddala KC, Lee CC, Meraner P, Marin M, Markosyan RM, Desai TM, Cohen FS, Brass AL, Melikyan GB. Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes. PLoS Pathog. 2019 Jan 14;15(1):e1007532. https://doi.org/10.1371/journal.ppat.1007532
- Surjit M, Liu B, Chow VTK, Lal SK. The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J Biol Chem. 2006 Apr;281(16): 10669–10681. https://doi.org/10.1074/jbc.M509233200
- Tang X, Wu C, Li X, Song Y, Yao X, Wu X, Duan Y, Zhang H, Wang Y, Qian Z, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. 2020 Jun 01;7(6):1012–1023. https://doi.org/10.1093/nsr/nwaa036
- Tarke A, Coelho CH, Zhang Z, Dan JM, Yu ED, Methot N, Bloom NI, Goodwin B, Phillips E, Mallal S, et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell. 2022 Mar 3;185(5): 847–859.e11. https://doi.org/10.1016/j.cell.2022.01.015
- Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N, et al. Emergence and rapid spread of a new severe acute respiratory syndrome related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv. 2020;2020.12.21.20248640. https://doi.org/10.1101/2020.12.21.20248640
- The Johns Hopkins Coronavirus Resource Center [Internet]. Baltimore (USA): Johns Hopkins University and Medicine; 2022 [cited 2022 Feb 4]. Available from https://coronavirus.jhu.edu
- Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, Jia X, Nicholson S, Catton M, Cowie B, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020 Apr;26(4):453–455. https://doi.org/10.1038/s41591-020-0819-2
- Tleyjeh IM, Kashour Z, Damlaj M, Riaz M, Tlayjeh H, Altan‑ nir M, Altannir Y, Al-Tannir M, Tleyjeh R, Hassett L, et al. Efficacy and safety of tocilizumab in COVID- 19 patients: a living systematic review and meta-analysis. Clin Microbiol Infect. 2021 Feb; 27(2): 215–227. https://doi.org/10.1016/j.cmi.2020.10.036
- Tomasiewicz K, Piekarska A, Stempkowska-Rejek J, Serafińska S, Gawkowska A, Parczewski M, Niścigorska-Olsen J, Łapiński TW, Zarębska-Michaluk D, Kowalska JD, et al. Tocilizumab for patients with severe COVID- 19: a retrospective, multi-center study. Expert Rev Anti Infect Ther. 2021 Jan 02;19(1):93–100. https://doi.org/10.1080/14787210.2020.1800453
- Torjesen I. COVID-19: omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ. 2021 Nov 29;375(2943):n2943. https://doi.org/10.1136/bmj.n2943
- Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, et al.; GTEx Consor‑ tium; Laboratory, Data Analysis &Coordinating Center (LDACC) – Analysis Working Group; Statistical Methods groups – Analysis Working Group; Enhancing GTEx (eGTEx) groups; NIH Com‑ mon Fund; NIH/NCI; NIH/NHGRI; NIH/NIMH; NIH/NIDA; Biospecimen Collection Source Site – NDRI; et al. Landscape of X chromosome inactivation across human tissues. Nature. 2017 Oct 12;550(7675):244–248. https://doi.org/10.1038/nature24265
- Vangeel L, Chiu W, De Jonghe S, Maes P, Slechten B, Rayme‑ nants J, André E, Leyssen P, Neyts J, Jochmans D. Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern. Antiviral Res. 2022 Feb; 198:105252. https://doi.org/10.1016/j.antiviral.2022.105252
- Veklury, Summary of product characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Jan 5]. Available from https://www.ema.europa.eu/en/documents/other/veklury-product-information-approved-chmp-25-june-2020-pending-endorsement-european-commission_en.pdf
- Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Apr;181(2):281–292.e6. https://doi.org/10.1016/j.cell.2020.02.058
- Wang W, Zhang W, Zhang J, He J, Zhu F. Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease‐2019 (COVID‐19). HLA. 2020 Aug;96(2):194–196. https://doi.org/10.1111/tan.13941
- Wein AN, McMaster SR, Takamura S, Dunbar PR, Cartwright EK, Hayward SL, McManus DT, Shimaoka T, Ueha S, Tsukui T, et al. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways. J Exp Med. 2019 Dec 02;216(12):2748–2762. https://doi.org/10.1084/jem.20181308
- Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, et al.; Trial Investigators. REGEN-COV antibody combination and outcomes in outpatients with COVID- 19. N Engl J Med. 2021 Dec 02;385(23):e81. https://doi.org/10.1056/NEJMoa2108163
- Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011;81:85–164. https://doi.org/10.1016/B978-0-12-385885-6.00009-2
- WHO. Classification of Omicron (B.1.1.529): SARS‐CoV‐2 variant of concern [Internet]. Geneva (Switzerland): World Health Organization; 2021 [cited 2022 Feb 04]. Available from https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern
- WHO. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: interim guidance, 19 March 2020 [Internet]. Geneva (Switzerland): World Health Organization; 2020 [cited 2022 Feb 04]. Available from https://apps.who.int/iris/handle/10665/331501
- WHO. Tracking SARS-CoV-2 variants [Internet]. Geneva (Switzerland): World Health Organization; 2022 [cited 2022 Feb 15]. Available from https://www.who.int/activities/tracking-SARS-CoV-2-variants
- Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). JAMA. 2020 Aug 25;324(8):782–793. https://doi.org/10.1001/jama.2020.12839
- Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 Mar13; 367(6483):1260–1263. https://doi.org/10.1126/science.abb2507
- Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020 Mar;27(3):325–328. https://doi.org/10.1016/j.chom.2020.02.001
- Xia X. Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense. Mol Biol Evol. 2020 Sep 01;37(9): 2699–2705. https://doi.org/10.1093/molbev/msaa094
- Xuan Y, Wang LN, Li W, Zi HR, Guo Y, Yan WJ, Chen XB, Wei PM. IFITM3 rs 12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis. Epidemiol Infect. 2015 Oct; 143(14):2975–2984. https://doi.org/10.1017/S0950268815000278
- Yamayoshi S, Sakai-Tagawa Y, Koga M, Akasaka O, Nakachi I, Koh H, Maeda K, Adachi E, Saito M, Nagai H, et al. Comparison of rapid antigen tests for COVID- 19. Viruses. 2020 Dec 10;12(12):1420. https://doi.org/10.3390/v12121420
- Yoshimoto FK. The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID- 19. Protein J. 2020 Jun;39(3):198–216. https://doi.org/10.1007/s10930-020-09901-4
- Yu H, Sun B, Fang Z, Zhao J, Liu X, Li Y, Sun X, Liang H, Zhong B, Huang Z, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID- 19 patients. Eur Respir J. 2020 Aug;56(2): 2001526. https://doi.org/10.1183/13993003.01526-2020
- Yuan Y, Cao D, Zhang Y, Ma J, Qi J, Wang Q, Lu G, Wu Y, Yan J, Shi Y, et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun. 2017 Apr;8(1):15092. https://doi.org/10.1038/ncomms15092
- Yüce M, Filiztekin E, Özkaya KG. COVID- 19 diagnosis – A review of current methods. Biosens Bioelectron. 2021 Jan;172:112752. https://doi.org/10.1016/j.bios.2020.112752
- Zang R, Castro MFG, McCune BT, Zeng Q, Rothlauf PW, Sonnek NM, Liu Z, Brulois KF, Wang X, Greenberg HB, et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020 May 19;5(47): eabc3582. https://doi.org/10.1126/sciimmunol.abc3582
- Zeng W, Liu G, Ma H, Zhao D, Yang Y, Liu M, Mohammed A, Zhao C, Yang Y, Xie J, et al. Biochemical characterization of SARS-CoV-2 nucleocapsid protein. Biochem Biophys Res Commun. 2020 Jun;527(3):618–623. https://doi.org/10.1016/j.bbrc.2020.04.136
- Zhang Y, Qin L, Zhao Y, Zhang P, Xu B, Li K, Liang L, Zhang C, Dai Y, Feng Y, et al. Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019. J Infect Dis. 2020 Jun 16;222(1):34–37. https://doi.org/10.1093/infdis/jiaa224
- Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, Zhang Z, Liu L, Liu T, Liu Y, et al. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis. 2021 Jul 15;73(2):328–331. https://doi.org/10.1093/cid/ciaa1150
- Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am J Respir Crit Care Med. 2020 Sep 01;202(5):756–759. https://doi.org/10.1164/rccm.202001-0179LE
- Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, et al. Risk factors of critical and mortal COVID- 19 cases: A systematic literature review and meta-analysis. J Infect. 2020 Aug;81(2):e16–e25. https://doi.org/10.1016/j.jinf.2020.04.021
- Zhou X, Cheng Z, Shu D, Lin W, Ming Z, Chen W, Hu Y. Characteristics of mortal COVID-19 cases compared to the survivors. Aging (Albany NY). 2020 Dec 31;12(24):24579–24595. https://doi.org/10.18632/aging.202216
- Zipeto D, Palmeira JF, Argañaraz GA, Argañaraz ER. ACE2/ ADAM17/TMPRSS2 Interplay may be the main risk factor for COVID-19. Front Immunol. 2020 Oct 7;11:576745. https://doi.org/10.3389/fimmu.2020.576745
- Zou J, Yin J, Fang L, Yang M, Wang T, Wu W, Bellucci MA, Zhang P. Computational prediction of mutational effects on SARS-CoV-2 binding by relative free energy calculations. J Chem Inf Model. 2020 Dec 28;60(12):5794–5802. https://doi.org/10.1021/acs.jcim.0c00679
- Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology. 2020 Aug;296(2):E15–E25. https://doi.org/10.1148/radiol.2020200490